To ascertain the function of PRAME knockdown on the growth of cervical tumor cells, PRAME-silenced C33A and SiHa cells were constructed through two sets of shRNA sequences, and the transfection efficiency was verified via Western blotting and qRT-PCR. The gene discussed is PRAME; the disease is uterine cervix neoplasm.